Yarrow Bioscience, Inc.

US$15.60As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:YARWHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (58.78%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 2.13
PE TTM —
TSR TTM 55.47%
Mkt cap US$145.1M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$19
24.76%
(83.78%)
Sell 5|6|6|10|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.32
0.34
0.35
0.36
1.75%
2.61%
2.71%
10.25%
Revenue$M
6.375
6.315
6.552
6.456
(0.93%)
(0.55%)
5.19%
1.64%
Peers (US$145.1M)
Cap (US$)
PE
148.4M
—
145.5M
13.73x
Capital
TTM
5Y
10Y
Leveragex
2.165
0.074
0.068
EBIT/Intx
14.55
0.125
0.132
Own earn%
202.29
(0.17)
6.47
Sh yield%
44.44
13.65
14.98
Owners
Insiders/Inst%
2.92
69.20
Short interest%
2.43
SBC / revenue%
2.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
8–12
$1 testx
—
Incr. ROIC%
7